HMNC Brain Health

There’s a new Success Story on our website! Find out how IMed Consultancy supported HMNC Brain Health in getting their Cortibon programme’s clinical trial off the ground here: https://lnkd.in/dTZ8-sM5 #imedconsultancy #hmncbrainhealth #successstories #cortibon #clinicaltrial

Attending CNS Summit 2024 in Boston? Connect with our CMO, Hans Eriksson, MD PhD MBA, and join us for an insightful panel discussion at the Psychedelic Forum Spotlight Session. More details on our participation here: https://lnkd.in/dZ4WGb8D #HMNCBrainHealth #PrecisionPsychiatry #CNSSummit #mentalhealth

Exploring KET01: A New Ketamine Therapy Option for Treatment-Resistant Depression   Join us at the European College of Neuropsychopharmacology (ECNP) Congress 2024, taking place on September 21-24 in Milan, to explore KET01, an oral prolonged-release formulation of ketamine that shows promise in Phase 2 trials for providing rapid depression relief with minimal side effects. We will present posters focused on the acute tolerability of KET01 and its minimal impact on sleep quality and sedation—addressing common concerns associated with current ketamine therapies.   📅 Date: September 22, 2024 🕒 Time: 12:35 to 14:00 CET 📍 Session: PS01 🔍 Posters: P1090 & P1084   For more detailed information, visit our press release here: https://lnkd.in/d8w5tXvD #MentalHealth #DepressionTreatment #Innovation #HealthcareNews #Ketabon #DevelcoPharma #HMNCBrainHealh 

The management team at HMNC Brain Health will be participating virtually in the 5th annual H.C. Wainwright & Co., LLC Neuro Perspectives Conference on June 27, 2024. Join Maximilian Doebler, Chief Business Officer, and Hans Eriksson, MD PhD MBA, Chief Medical Officer, as they lead our company presentation, discussing "The Path to Precision Psychiatry" and its applications in treating Major Depressive Disorder (MDD). The recording of HMNC’s presentation will be available on-demand starting at 7:00 am ET. Access the conference via the following link: https://lnkd.in/eJnTDYsv #HMNCBrainHealth #PrecisionPsychiatry

Collaboration Announcement We are thrilled to announce a strategic collaboration between HMNC Brain Health and Spruce Biosciences to advance the treatment of Major Depressive Disorder (MDD). https://lnkd.in/gP-mnv6w This partnership aims to combine Spruce's investigational product candidate, tildacerfont, with HMNC's proprietary companion diagnostic, Cortibon Genetic Selection Tool.   🔬 Key Highlights:   Combination Therapy: tildacerfont, a second-generation CRF1 receptor antagonist, paired with HMNC’s Cortibon Genetic Selection Tool to identify MDD patients responsive to the targeted treatment. Phase 2 Study: HMNC will initiate a Phase 2 proof-of-concept study later this year.   This collaboration shows our joint commitment to precision psychiatry, addressing patient heterogeneity, and enhancing treatment efficacy through personalized medicine.   We will share more updates as we embark on this journey towards better mental health solutions. #HMNCBrainHealth #personalizedmedicine #depression #depressiontreatment #Collaboration #Innovation

HMNC Brain Health will present poster presentations at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting taking place on May 28-31, 2024 at Miami Beach. (https://lnkd.in/djxr3sG) Hans Eriksson, MD PhD MBA, Chief Medical Officer of Ketabon and HMNC Brain Health, will elucidate details on topline results of our Phase 2 trial with KET01, an oral ketamine treatment with minimal dissociative adverse effects, showing rapid improvement in depression severity and Ketabon’s comparative tolerability study between KET01 and intranasal SPRAVATO®, the current FDA-approved ketamine formulation. It’s an excellent opportunity for us to engage with leaders in the field and we're deeply grateful for the opportunity to continue advancing alternative treatments for patients grappling with treatment-resistant depression. Stay tuned for updates as we continue to push the boundaries of innovation in mental health care. #HMNCBrainHealth #personalizedmedicine #mentalhealthmatters #depression #mentalhealthawareness #depressiontreatment

"Mental Health Awareness Month: Elevating Care with Precision Psychiatry" This Mental Health Awareness Month, we at HMNC Brain Health are dedicated to advancing the understanding and treatment of mental health disorders through precision psychiatry. Mental health is as important as physical health, yet it often lacks the same level of awareness and support. 💢 Why Focus on Mental Health? Universal Impact: Mental health issues affect one in five adults globally, impacting life quality, relationships, and work productivity. Innovation in Treatment: We’re pioneering efforts to tailor psychiatric treatments to individual factors, resulting in predictive efficacy in selected populations. 🌟 Our Commitment: At HMNC Brain Health, we’re not just researching; we’re trying to significantly simplify the way mental health conditions are understood and treated. Our goal? To provide hope and better outcomes for patients worldwide through targeted, science-based therapies. 🤝 Join Us: #StayInformed: Follow our page (https://lnkd.in/dQYpKwby) for the latest updates in mental health research and innovations. Together, we can break the stigma and change the landscape of mental health care. #MentalHealthAwarenessMonth #HMNCBrainHealth #PrecisionPsychiatry #MentalHealthMatters #BreakTheStigma

🌟 Meet Dr. Dr. Jessica Burgstaller, Our Chief of Staff at HMNC Brain Health At HMNC Brain Health, we value the diverse expertise of our team members who drive our mission forward. Today, we’re spotlighting Dr. Dr. Jessica Burgstaller to learn more about her critical role and perspective on precision psychiatry's future. Jessica, your role as Chief of Staff is pivotal at HMNC. Can you share how you orchestrate operations and strategy within our organization? At HMNC Brain Health I work closely with the executive team to refine our strategic vision and oversee key projects to ensure effective execution. What I enjoy most is being close to all teams and people, listening to their ideas, understanding their perspectives, supporting cross-functional collaboration, and aligning projects and initiatives. What inspired you to join HMNC Brain Health, and how do you see your background influencing your current role? I have witnessed the heartbreaking shortcomings of current approaches to treating mental health disorders and joined HMNC because I believe in our precision psychiatry approach and the potential to reshape the entire treatment landscape of depression. With my scientific research background complemented by practical expertise from 4 years of strategy management consulting in the Life Science sector, I feel well-equipped to facilitate cross-functional collaboration and represent HMNC in external engagements, contributing to HMNC’s overall success. In your view, how does HMNC contribute to advancing patient care globally? At HMNC Brain Health, we are not just developing a product but striving to shift paradigms in mental health care. We drive the development of genetic selection tools for psychiatry to facilitate targeted therapies for various subtypes of depression and other psychiatric disorders, laying a robust foundation for future advancements in precision psychiatry. This could revolutionize the field and I am proud and grateful to be part of this inspiring mission! We are thrilled to have Jessica's strategic acumen guiding our team as we innovate in the field of precision psychiatry. #HMNCBrainHealth #Leadership #Team #personalizedmedicine #mentalhealthmatters  #depression #mentalhealthawareness #depressiontreatment

🧠 A Personalized Approach to Mental Health Our CMO Hans Eriksson, MD PhD MBA shares compelling thoughts on precision psychiatry in Psychology Today. It's all about tailoring treatment to the individual's unique needs—a principle that guides our work at HMNC. With our approach, we start with an understanding of the disease biology. We use a medication developed to overcome the specific biological disturbance, and finally, we use a specific test to identify individuals more likely to respond to the treatment. Thereby, we go full circle. https://lnkd.in/dgd7gk3r #PrecisionPsychiatry #HMNC #MentalHealth

To everyone invested in the future of mental health care, this episode is a must-listen! 🌟 #HMNCBrainHealth #personalizedmedicine #mentalhealthmatters  #depression #depressiontreatment https://lnkd.in/g5iS_PDJ